Published September 6, 2025
0 views Journal article Open Access Open Access

Pathophysiology and treatment of exercise-associated hyponatremia.

  • 1. Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany.
  • 2. University of Würzburg
  • 3. Department of Medicine and Surgery, Division of Endocrinology and Metabolic Diseases, University of Parma, Parma, Italy.
  • 4. Endocrinology Unit, Azienda Ospedaliera Universitaria Sassari, Sassari, Italy.
  • 5. Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
  • 6. Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
  • 7. University of Florence
  • 8. Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.
  • 9. Sapienza University of Rome
  • 10. Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • 11. Division of Endocrinology and Andrology, Department of Experimental Medicine, Sapienza University, Rome, Italy.
  • 12. UNESCO Chair Education for Health and Sustainable Development, Federico II University, Naples, Italy.
  • 13. Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy. alessandro.peri@unifi.it.
  • 14. Pituitary Diseases and Sodium Alterations Unit, Endocrinology, Careggi University Hospital, Florence, 50139, Italy. alessandro.peri@unifi.it.

Description

Exercise associated hyponatremia (EAH) is a medical condition that can occur during physical exertion. Initially, EAH was considered to be restricted to extreme endurance activities, such as ultramarathons and Ironman triathlons. However, it has been more recently recognized in a variety of sports, including team sports and in shorter-duration events. The pathophysiology of EAH is multifactorial and includes excessive fluid intake and non-osmotic arginine vasopressin secretion, which is induced by physical activity. Sodium loss through sweat appears to play a less important role in contributing to EAH. The clinical presentation may vary, depending on the degree of serum sodium reduction. Symptoms, which are due to increased intracranial pressure, may vary from nausea, vomiting, headache, confusion to severe alterations in cognitive functions, decorticate posturing, respiratory distress, coma and even death. It is of pivotal importance to differentiate EAH from other conditions that may present with similar signs/symptoms, such as for instance hypoglycemia, orthostatic hypotension, vasovagal syncope, heat stroke. The treatment of EAH depends on the severity of symptoms. In life-threatening situations intravenous infusion of hypertonic saline solution (3%NaCl) is recommended. In less severe situations oral hypertonic saline solutions can be administered, as an alternative to intravenous hypertonic saline, when tolerated by patients. When symptoms are negligible, the treatment can be limited to fluid restriction. Effective strategies to prevent EAH would be important to reduce the risk of incurring in potentially life-threatening situations. In particular, recommendations to drink in anticipation of thirst during physical exertions should be replaced by the "drinking when thirsty" strategy.
Enabled by The Lens

Open Access

Licence Attribution (CC BY)
Publisher Website Access full text